Showing results (321-330 of 356) with videos related to

Sort By:
Pageof 36
The Journal of Biological Chemistry|May 17, 2001
Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functionsH H Zhao, R E Herrera, E Coronado-Heinsohn, et al.
Wires Mechanisms of Disease|October 1, 2020
Spatiotemporal strategies to identify aggressive biology in precancerous breast biopsiesDavid E Frankhauser, Tijana Jovanovic-Talisman, Lily Lai, et al.
Breast Cancer Research : BCR|June 23, 2025
Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trialRoberto A Leon-Ferre, K Dimitroff, C Yau, et al.
ACS Applied Materials & Interfaces|January 15, 2020
Additive Manufacturing of Optical Quality Germania-Silica GlassesKoroush Sasan, Andrew Lange, Timothy D Yee, et al.
Cancer|October 20, 2020
Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patientsMichelle J Naughton, Heshan Liu, Drew K Seisler, et al.
Genomics|February 13, 2001
Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoformsJ L Reiter, D W Threadgill, G D Eley, et al.
Cancer|October 20, 2020
A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance)Electra D Paskett, Jennifer Le-Rademacher, Jill M Oliveri, et al.
Plos One|October 11, 2012
Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model systemNicholas C D'Amato, Julie H Ostrander, Michelle L Bowie, et al.
Neoplasia (New York, N.Y.)|May 15, 2017
Stromal PDGFR-α Activation Enhances Matrix Stiffness, Impedes Mammary Ductal Development, and Accelerates Tumor GrowthAnisha M Hammer, Gina M Sizemore, Vasudha C Shukla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2024
Pathologic complete response (pCR) rates for patients with HR+/HER2- high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trialL A Huppert, D Wolf, C Yau, et al.
Pageof 36